Nancy Lynn Md Snyderman Alkermes Plc. (ALKS) insider trading activity

Nancy Lynn Md Snyderman is Director of Alkermes plc.. Currently has a direct ownership of 20,783 shares of ALKS, which is worth approximately $500,870. The most recent transaction as insider was on Jul 07, 2023, when has been sold 1,430 shares (Ordinary Shares) at a price of $29.88 per share, resulting in proceeds of $42,728. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.8K

0% 3M change

27.85% 12M change

Total Value Held $500,870

nancy lynn MD snyderman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 07 2023	SELL Payment of exercise price or tax liability	$42,728 $29.88 p/Share	1,430 Reduced 6.44%	20,783 Ordinary Shares
Jul 07 2023	BUY Exercise of conversion of derivative security	-	5,957 Added 21.15%	22,213 Ordinary Shares
Jun 14 2022	SELL Payment of exercise price or tax liability	$18,897 $27.19 p/Share	695 Reduced 4.1%	16,256 Ordinary Shares
Jun 14 2022	BUY Exercise of conversion of derivative security	-	7,585 Added 30.91%	16,951 Ordinary Shares
Mar 04 2022	BUY Open market or private purchase	$10,005 $23.43 p/Share	427 Added 4.36%	9,366 Ordinary Shares
Dec 02 2021	SELL Payment of exercise price or tax liability	$29,605 $22.11 p/Share	1,339 Reduced 13.03%	8,939 Ordinary Shares
Dec 02 2021	BUY Exercise of conversion of derivative security	-	5,578 Added 35.18%	10,278 Ordinary Shares

May 20 2021	SELL Payment of exercise price or tax liability	$30,776 $21.92 p/Share	1,404 Reduced 23.0%	4,700 Ordinary Shares
May 20 2021	BUY Exercise of conversion of derivative security	-	6,104 Added 50.0%	6,104 Ordinary Shares

Also insider at

LYRA

Lyra Therapeutics, Inc. Healthcare

FHLTU

Future Health ESG Corp. Financial Services

Director

AXNX

Axonics, Inc. Healthcare

nlM